India tightens penalties for submitting false regulatory documents

The Indian government has introduced stricter penalties for applicants who submit misleading, fake, or fabricated documents to regulatory authorities, prohibiting them from making further filing requests.

The new rule is intended to improve the integrity of submissions and deter misconduct, impacting pharmaceutical and medical-device companies that seek approvals.

In parallel, the International Medical Device Regulators Forum released a technical document on predetermined change control plans, outlining principles for regulators and manufacturers to adopt, underscoring a global push for tighter regulatory standards.